<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01880970</url>
  </required_header>
  <id_info>
    <org_study_id>07.20.INF</org_study_id>
    <nct_id>NCT01880970</nct_id>
  </id_info>
  <brief_title>Effect of Starter Formula on Infection Prevention</brief_title>
  <official_title>Effect of Starter Formula With Synbiotics on Prevention of Gastro-intestinal Infections and All Infections With Fever in Full Term Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to test the efficacy of an infant formula containing synbiotics on
      the prevention of gastro-intestinal infections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diarrhea and all infections with fever</measure>
    <time_frame>over 6 months and 1 year</time_frame>
    <description>Mean event rate of diarrhea and all infections with fever per child over 6 months and 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>over 6 months and 1 year</time_frame>
    <description>Frequency of episodes of morbidity (adverse events), especially mean event rate of respiratory illnesses per child over 6 months and 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>until 1 year</time_frame>
    <description>Anthropometry (weight (kg), length (cm), head circumference (cm) and skin fold)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digestive tolerance</measure>
    <time_frame>until 1 year</time_frame>
    <description>Digestive tolerance (stool characteristics and frequency, vomiting, regurgitation, frequency of colic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool characteristics</measure>
    <time_frame>at 3 and 6 months</time_frame>
    <description>Stool bacterial populations (Bifidobacteria, Lactobacilli Species, Clostridium, Bacteroides, Staphylococci epidermitis, presence or absence of B. lactis)
Stool pH
Stool and saliva S.IgA
Stool Alpha 1-antitrypsine as infection/inflammation marker</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">477</enrollment>
  <condition>Gastro-intestinal Infections</condition>
  <condition>Infections With Fever</condition>
  <arm_group>
    <arm_group_label>Starter infant formula with pro and prebiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>starter infant formula from enrollment till 6 months of age, followed by a commercially available Nestlé follow-up formula from 6 to 12 months of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>starter infant formula without pro and prebiotics</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>starter infant formula from enrollment till 6 months of age, followed by a commercially available Nestlé follow-up formula from 6 to 12 months of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breastfeeding group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>exclusively breastfeeding during the first 3 months of age, followed by a commercially available Nestlé starter infant formula from 4 to 6 months of age (if applicable) and the follow-up infant formula from 6 to 12 months of age</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>starter infant formula with pro and prebiotics</intervention_name>
    <arm_group_label>Starter infant formula with pro and prebiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo comparator</intervention_name>
    <arm_group_label>starter infant formula without pro and prebiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy newborn infant

          -  Full term infant (≥ 37 weeks gestation; ≤ 42 weeks gestation)

          -  Age of infant is ≤ 13 days at the time of enrollment

          -  Birth weight ≥ 2500g and ≤ 4500g

          -  For the FF groups: The infant's mother has elected not to breastfeed

          -  For the BF group: The infant's mother has elected to fully breastfeed her baby, from
             enrollment to at least 3 months of age

          -  Having obtained his/her legal representative's informed consent

        Exclusion Criteria:

          -  Congenital illness or malformation that may affect normal growth (especially
             immunodeficiencies)

          -  Significant pre-natal and/or post-natal diseases

          -  Perinatal antibiotic or infants on antibiotics at the time of inclusion

          -  Infants whose mother has had an acute infection during the last month of pregnancy

          -  Re-hospitalisation for more than 2 days in the first 14 days of life (exceptionally,
             infants re-hospitalized because of jaundice may be enrolled in the study)

          -  Receiving infant formula containing probiotics and/or prebiotics at the time of
             enrollment

          -  Newborn whose parents / caregivers cannot be expected to comply with treatment

          -  Newborn currently participating in another interventional clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Michel Hascoet, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternité régionale de Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital de la Croix Rousse, Service de réanimation néonatale</name>
      <address>
        <city>Lyon</city>
        <zip>69317</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Arnaud de Villeneuve, Service de pédiatrie 2</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternité régionale de Nancy, Service de Néonatologie</name>
      <address>
        <city>Nancy</city>
        <zip>54042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Campus Virchow-Klinikum, Klinik für Geburtsmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg, Zentrum für Kinderheilkunde und Jugendmedizin</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ernest von Bergmann, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vrije Universiteit Medisch Centrum, Afdeling Kindergeneeskunde</name>
      <address>
        <city>Amsterdam</city>
        <zip>1007 MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2013</study_first_submitted>
  <study_first_submitted_qc>June 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2013</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Trematode Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

